Scarica l'app Stockscreener
2.76
0.73%
0.02
Dopo l'orario di chiusura:
2.71
-0.05
-1.81%
Precedente Chiudi:
$2.74
Aprire:
$2.82
Volume 24 ore:
27,424
Relative Volume:
1.17
Capitalizzazione di mercato:
$3.81M
Reddito:
$357.90K
Utile/perdita netta:
$-11.06M
Rapporto P/E:
-2.4641
EPS:
-1.1201
Flusso di cassa netto:
$-11.90M
1 W Prestazione:
-3.97%
1M Prestazione:
-31.34%
6M Prestazione:
-51.54%
1 anno Prestazione:
-91.21%
Intervallo 1D:
$2.7013
$2.82
Intervallo di 1 settimana:
$2.61
$3.23
Portata 52W:
$2.61
$34.60
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Nome
Biorestorative Therapies Inc
Settore
Industria
Telefono
(631) 760-8100
Indirizzo
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
2.76 | 3.78M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
BioRestorative Therapies, Inc. Revenue Breakdown – MUN:9OF0 - TradingView
BioRestorative Therapies, Inc. Earnings and Revenue – FWB:9OF0 - TradingView
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Biorestorative Therapies To Carry Out 1-for-20 Reverse Stock Split On September 8th, 2026 - Moomoo
BioRestorative Therapies Announces Reverse Stock Split - Ortho Spine News
BioRestorative Therapies Announces 1-for-20 Reverse Stock Split - TipRanks
Biorestorative Therapies Announces Reverse Stock Split - TradingView
BioRestorative Therapies: Board Approves 1-For-20 Reverse Split >BRTX - Moomoo
BioRestorative Therapies Names New Interim CEO and CFO - Minichart
BioRestorative Therapies Inc (BRTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BioRestorative Therapies Inc (BRTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioRestorative Therapies Inc (BRTX) Peer Comparison – Compare with Others - Value Research
BRTX Q1 2026 Earnings: Narrower Net Loss Beats Estimates as Pipeline AdvancesQuarterly Earnings Report - vinanet.vn
BioRestorative Therapies Faces Nasdaq Delinquency Notice Risk - TipRanks
BioRestorative Therapies Received Notice of Noncompliance - TradingView
BioRestorative (BRTX) Chart: Slides 0.98% to $0.21 for the Current Session; Price Levels: Price Remains Between $0.20 Support and $0.22 Resistance in the Latest ReadingFibonacci Retracement - vinanet.vn
BioRestorative (BRTX) Move: Retreats 2.40% to $0.22 for the Current Session; Range Check: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingVolume Spike Alerts - vinanet.vn
BioRestorative Therapies Halts ExoCR and BioX Shipments - TipRanks
MSN Money - MSN
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Manufacturing Readiness in Focus Today? - Kalkine Media
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Funding in Focus Today? - Kalkine Media
BRTX Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeFundamentals - dars.gov.et
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Nigeria
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com Australia
BioRestorative Therapies Delays Quarterly SEC Filing - TipRanks
Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7 - TradingView
BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan
BioRestorative Therapies, Inc. Suspends All Orders And Shipments Of Biocosmeceutical Product Lines - marketscreener.com
BRTX Q2'26 Earnings: revenue estimate is 600.00K USD - TradingView
BRTX Q1 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS SurpriseRevenue Guidance Update - vinanet.vn
BioRestorative Therapies Inc (BRTX) Stock News Today - TradingKey
BioRestorative Therapies (BRTX) Edges Lower, Holds $0.20 Support as Price Action TightensSupply Zone - vinanet.vn
BioRestorative Therapies (BRTX) investor Alta Partners reports 4.99% ownership cap - Stock Titan
BRTX Q1 2026 Earnings: Loss Beats Estimates by 41.18% While Shares Fall 9.22%Revenue Recognition Risk - vinanet.vn
BioRestorative Therapies (BRTX) reports director Esha Randhawa’s insider status - Stock Titan
BioRestorative Therapies Inc - TradingKey
BioRestorative Therapies Inc (BRTX) Balance Sheet - TradingKey
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.219|Chg%:+0.018 - TradingKey
BioRestorative Therapies Inc (BRTX) Cash Flow - TradingKey
BioRestorative Therapies Inc (BRTX) Income Statement - tradingkey.com
BRTX|BioRestorative Therapies Inc|Price:0.270|Chg%:-0.007 - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.282|Chg%:-0.008 - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.226|Chg%:+0.006 - TradingKey
BioRestorative Therapies (BRTX) Slides 7% – Testing Critical Support at $0.28Institutional Sentiment - vinanet.vn
BioRestorative Therapies, Inc. Revenue Breakdown – GETTEX:9OF - TradingView
Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):